Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZIN UND POLYMORPHE FORMEN DAVON
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019769738
EP Publication Number
3849977
E-Number
1589375
Language
EN
PCT Number
EP19074083
Publication Date
21.07.2021 A
19.07.2023 B1
Registration Date
19.07.2023
AT Publication Date
15.08.2023
Application Date
10.09.2019
Registration Number
-
Priorities
11.09.2018
WO
PCT/CN2018/104941
IPC
C07D 471/04 20060101AFI20200321BHEP
Maximum Duration of Protection
10.09.2039
Owner
Astrazeneca AB 151 85 SödertäljeSE
Hutchison Medipharma LimitedBuilding 4 720 Cai Lun Road Pilot Free Zone Shanghai 201203CN
Representative
No representatives present
Inventor
TURNER, Andrew, RoyAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB
TURNER, Andrew, TimothyAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB
HOWELL, Gareth, PaulAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB
GALL, Malcolm, Allan, YoungAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB
MULHOLLAND, Keith, RaymondAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB
ADLINGTON, Neil, KeithAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB
TIAN, Zhenping243 North Gongye Road Jinan, Shandong 250100CN